GÜMÜŞLÜ, S. 2013. Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200. Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , (Taipei, Taiwan), 20.

GÜMÜŞLÜ, S., (2013). Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200 . Asia Pacific Congress of Allergy, Asthma and Clinical Immunology (pp.20). Taipei, Taiwan

GÜMÜŞLÜ, SAADET. "Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200," Asia Pacific Congress of Allergy, Asthma and Clinical Immunology, Taipei, Taiwan, 2013

GÜMÜŞLÜ, SAADET. "Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200." Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , Taipei, Taiwan, pp.20, 2013

GÜMÜŞLÜ, S. (2013) . "Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200." Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , Taipei, Taiwan, p.20.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200}, congress name={Asia Pacific Congress of Allergy, Asthma and Clinical Immunology}, city={Taipei}, country={Taiwan}, year={2013}, pages={20} }